A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia-Reference-Cited by-同舟云学术

A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia

Published:2013-08 Issue:8 Volume:33 Page:2021-2025
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:Arterioscler Thromb Vasc Biol.

Author:

Cefalù Angelo B.¹,Pirruccello James P.¹,Noto Davide¹,Gabriel Stacey¹,Valenti Vincenza¹,Gupta Namrata¹,Spina Rossella¹,Tarugi Patrizia¹,Kathiresan Sekar¹,Averna Maurizio R.¹

Affiliation:

1. From the Dipartimento Biomedico di Medicina Interna e Specialistica, Università degli Studi di Palermo, Palermo, Italy (A.B.C., D.N., V.V., R.S., M.R.A.); Center for Human Genetic Research (J.P.P., S.K.), and Cardiovascular Research Center (J.P.P., S.K.), Massachusetts General Hospital, Boston, MA; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA (J.P.P., S.G., N.G., S.K.); Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy (P.T.); and...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Molecular diagnosis of hypobetalipoproteinemia: An ENID review

2. Familial hypobetalipoproteinemia: a review

3. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9

4. A Novel Loss of Function Mutation of PCSK9 Gene in White Subjects With Low-Plasma Low-Density Lipoprotein Cholesterol

5. Genetic variants in PCSK9 in the Japanese population: Rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Role of Bempedoic Acid in Metabolic Dysfunction Associated Steatotic Liver Disease: Actual Evidence and Future Perspectives;International Journal of Molecular Sciences;2024-06-25

2. Impaired Hepatic Very Low-Density Lipoprotein Secretion Promotes Tumorigenesis and Is Accelerated with Fabp1 Deletion;The American Journal of Pathology;2024-06

3. Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin;Frontiers in Endocrinology;2024-05-23

4. Combination of heterozygous APOB gene mutation with PNPLA3 and TM6SF2 variants promotes steatotic liver disease, cirrhosis and HCC development;Liver International;2024-02-29

5. Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics;Biomedicines;2023-10-17